CME Stock Overview
Engages in the acquisition, exploration, evaluation, and development of mineral properties in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Canadian Metals Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.055 |
| 52 Week High | CA$0.25 |
| 52 Week Low | CA$0.01 |
| Beta | 1.55 |
| 11 Month Change | -42.11% |
| 3 Month Change | -57.69% |
| 1 Year Change | -56.00% |
| 33 Year Change | -92.67% |
| 5 Year Change | -94.21% |
| Change since IPO | -99.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| CME | CA Metals and Mining | CA Market | |
|---|---|---|---|
| 7D | -8.3% | -0.6% | 1.0% |
| 1Y | -56.0% | 25.4% | 23.0% |
Return vs Industry: CME underperformed the Canadian Metals and Mining industry which returned 31.8% over the past year.
Return vs Market: CME underperformed the Canadian Market which returned 24% over the past year.
Price Volatility
| CME volatility | |
|---|---|
| CME Average Weekly Movement | n/a |
| Metals and Mining Industry Average Movement | 10.5% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CA Market | 17.8% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: CME's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine CME's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | n/a | Beat Frei | canadian-metals.com |
Canadian Metals Inc. engages in the acquisition, exploration, evaluation, and development of mineral properties in Canada. It explores for silica, zinc, polymetallic, gold, and silver ores. Canadian Metals Inc. was incorporated in 2012 and is headquartered in Montreal, Canada.
Canadian Metals Inc. Fundamentals Summary
| CME fundamental statistics | |
|---|---|
| Market cap | CA$1.56m |
| Earnings (TTM) | -CA$703.28k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-2.4x
P/E RatioIs CME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CME income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$703.28k |
| Earnings | -CA$703.28k |
Last Reported Earnings
Apr 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.023 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 8.4% |
How did CME perform over the long term?
See historical performance and comparison